Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human HIF-2 alpha/EPAS1 Antibody, R&D Systems™

Rabbit Monoclonal Antibody
Supplier: R&D Systems MAB2997100
This item is not returnable.
View return policy
Description
HIF-2 alpha/EPAS1 Monoclonal specifically detects HIF-2 alpha/EPAS1 in Human samples. It is validated for Western Blot, Immunocytochemistry.Specifications
| HIF-2 alpha/EPAS1 | |
| Monoclonal | |
| Unconjugated | |
| Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. | |
| Basic-helix-loop-helix-PAS protein MOP2, BHLHE73, Class E basic helix-loop-helix protein 73, ECYT4, endothelial PAS domain protein 1, endothelial PAS domain-containing protein 1, EPAS1, EPAS-1, HIF 2A, HIF-1-alpha-like factor, HIF-1alpha-like factor, HIF2 alpha, HIF-2 alpha, HIF2A, hif2a angiogenesis, HIF-2-alpha, HIF2-alpha, HLF, hypoxia-inducible factor 2 alpha, Hypoxia-inducible factor 2-alpha, Member of PAS protein 2, MOP2, PAS domain-containing protein 2, PASD2 | |
| E. coli-derived recombinant human HIF-2 alpha/EPAS1, Ser543-Thr870, Accession # Q99814 | |
| 100 μg | |
| 2034 | |
| Reconstitute at 0.5 mg/mL in sterile PBS. | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month, 2 to 8°C under sterile conditions after reconstitution. 6 months, -20 to -70°C under sterile conditions after reconstitution. | |
| IgG |
| Western Blot, Immunocytochemistry | |
| 2444A | |
| Western Blot 2 μg/mL, Immunocytochemistry 3-25 μg/mL | |
| Q99814 | |
| Rabbit | |
| Protein A or G purified from cell culture supernatant | |
| Primary | |
| Detects human HIF-2 alpha/EPAS1 in direct ELISAs. | |
| Human | |
| Supernatant |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction